Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ganoderma Lucidum Mushroom for the Treatment of Cardiovascular Risk Factors." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438386/1/H1_antihistamines_for_chronic_spontaneous_urticaria:_Cochrane_systematic_review. Accessed 26 April 2024.
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/1/H1_antihistamines_for_chronic_spontaneous_urticaria:_Cochrane_systematic_review. Accessed April 26, 2024.
Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/1/H1_antihistamines_for_chronic_spontaneous_urticaria:_Cochrane_systematic_review
Ganoderma Lucidum Mushroom for the Treatment of Cardiovascular Risk Factors [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/1/H1_antihistamines_for_chronic_spontaneous_urticaria:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
ID - 438386
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438386/1/H1_antihistamines_for_chronic_spontaneous_urticaria:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -